Using a digital app to help reduce opioid and cocaine use in patients on methadone treatment
Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology
This study is testing if a digital app can help people using methadone for opioid and cocaine addiction stay in treatment longer and use less drugs over a year.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 240 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Friends Research Institute, Inc. Academic / other |
| Locations | 5 sites (Baltimore, Maryland and 4 other locations) |
| Trial ID | NCT05766631 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the DynamiCare app in conjunction with standard methadone treatment for individuals with both opioid and cocaine use disorders. Participants will be randomly assigned to either receive the app alongside their usual methadone treatment or to continue with standard treatment alone. The study aims to assess whether the app improves retention in treatment, reduces substance use, and enhances quality of life over a 12-month period. Data will be collected through treatment records and follow-up assessments at multiple time points.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have self-reported cocaine use in the past 30 days and are willing to provide informed consent.
Not a fit: Patients with severe psychiatric disorders, those on home detention, or individuals with visual impairments that hinder app use may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved treatment outcomes and quality of life for patients struggling with polysubstance use disorders.
How similar studies have performed: Other studies have shown promise in using digital interventions for substance use disorders, suggesting potential for success with this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 or older 2. Cocaine use (self-reported in the past 30 days) 3. Willing and able to provide informed consent Exclusion Criteria: 1. Severe psychiatric disorders 2. On home detention 3. Visual impairment that would make the use of the phone app impractical 4. Living arrangement that currently restricts phone access
Where this trial is running
Baltimore, Maryland and 4 other locations
- Friends Research Institute, Inc. Central Office — Baltimore, Maryland, United States (Recruiting)
- Glenwood Life Counseling Center — Baltimore, Maryland, United States (Recruiting)
- Institutes for Behavior Resources — Baltimore, Maryland, United States (Recruiting)
- Man Alive — Baltimore, Maryland, United States (Recruiting)
- BD Health Services, Inc. -- Dundalk — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Karen Alexander, Ph.D. — Friends Research Institute, Inc.
- Study coordinator: Karen Alexander, Ph.D.
- Email: kalexander@friendsresearch.org
- Phone: 267-398-3560
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.